Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
- PMID: 20092609
- PMCID: PMC2875491
- DOI: 10.1186/cc8211
Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
Comment on
-
Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?Crit Care. 2009;13(6):1006. doi: 10.1186/cc8156. Epub 2009 Dec 1. Crit Care. 2009. PMID: 20017890 Free PMC article.
References
-
- Lorente L, Martin MM, Labarta L, Diaz C, Sole-Violan J, Blanquer J, Orbe J, Rodriguez JA, Jimenez A, Borreguero-Leon JM, Belmonte F, Medina JC, Lliminana MC, Ferrer-Aguero JM, Ferreres J, Mora ML, Lubillo S, Sanchez M, Barrios Y, Sierra A, Paramo JA. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care. 2009;13:R158. doi: 10.1186/cc8115. - DOI - PMC - PubMed
-
- Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect. 2006;38:867–872. doi: 10.1080/00365540600702058. - DOI - PubMed
-
- Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. Am J Med Sci. 1998;316:355–360. doi: 10.1097/00000441-199812000-00001. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical